Chapter title |
Epigenetic markers of prognosis in melanoma.
|
---|---|
Chapter number | 25 |
Book title |
Molecular Diagnostics for Melanoma
|
Published in |
Methods in molecular biology, January 2014
|
DOI | 10.1007/978-1-62703-727-3_25 |
Pubmed ID | |
Book ISBNs |
978-1-62703-726-6, 978-1-62703-727-3
|
Authors |
Luca Sigalotti, Elisabetta Fratta, Giulia Parisi, Sandra Coral, Michele Maio, Sigalotti, Luca, Fratta, Elisabetta, Parisi, Giulia, Coral, Sandra, Maio, Michele |
Abstract |
Prognostic molecular markers are urgently needed for allowing to discriminate the clinical course of disease of melanoma patients, which is highly heterogeneous and unpredictable also within a specific clinicopathological stage and substage of disease. Alterations in DNA methylation have been reported to be widely present in cutaneous melanoma, profoundly impacting its biology. In line with this notion, we have identified methylation markers as independent prognostic factors in stage IIIC melanoma patients. In this chapter we describe the measurement of the methylation of the Long Interspersed Nucleotide Element-1 sequences in laser capture microdissected tumor tissues as a prognostic tool in stage III melanoma patients, which could help in achieving a more appropriate and patient-tailored clinical management of cutaneous melanoma. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 14 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 4 | 29% |
Student > Ph. D. Student | 2 | 14% |
Other | 1 | 7% |
Student > Doctoral Student | 1 | 7% |
Student > Master | 1 | 7% |
Other | 2 | 14% |
Unknown | 3 | 21% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 7 | 50% |
Agricultural and Biological Sciences | 3 | 21% |
Neuroscience | 1 | 7% |
Unknown | 3 | 21% |